일본의 면역조직화학 시장 보고서 : 제품, 용도, 최종사용자, 지역별(2025-2033년)
Japan Immunohistochemistry Market Report by Product (Antibodies, Equipment, Reagents, Kits), Application (Diagnostics, Drug Testing), End User (Hospitals and Diagnostic Laboratories, Research Institutes, and Others), and Region 2025-2033
상품코드:1609868
리서치사:IMARC
발행일:On Demand Report
페이지 정보:영문 117 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
일본의 면역조직화학 시장의 시장 규모는 2024년에 1억 7,770만 달러에 달했습니다. IMARC Group은 2025-2033년 성장률(CAGR)이 6.1%로, 2033년에는 3억 2,120만 달러에 달할 것으로 예측하고 있습니다. 노화에 관련한 질환의 유병률 증가, 강력한 헬스케어 인프라의 존재, 맞춤형 의료에 대한 의식의 향상, 의학 연구에 대한 정부에 의한 자금 제공이나 지원의 증가, 병리학 분야에서 최근 진보 등이 시장을 촉진하는 주요 요인입니다.
본 리포트에서 답변하는 주요 질문
일본의 면역조직화학 시장은 지금까지 어떻게 추이해 왔으며, 향후 어떻게 추이하는가?
일본의 면역조직화학 시장에 대한 COVID-19의 영향은?
일본의 면역조직화학 시장의 제품별 내역은?
일본의 면역조직화학 시장의 용도별 내역은?
일본의 면역조직화학 시장의 최종사용자별 내역은?
일본의 면역조직화학 시장의 밸류체인에는 어떤 단계가 있는가?
일본의 면역조직화학에서 주요 촉진요인과 과제는 무엇인가?
일본의 면역조직화학 시장의 구조와 주요 기업은?
일본의 면역조직화학 시장에서 경쟁의 정도는?
목차
제1장 서문
제2장 조사 범위와 조사 방법
조사의 목적
이해관계자
데이터 소스
시장 추정
조사 방법
제3장 개요
제4장 일본의 면역조직화학 시장 : 서론
개요
시장 역학
업계 동향
경쟁 정보
제5장 일본의 면역조직화학 시장 구도
과거 및 현재 시장 동향(2019-2024년)
시장 예측(2025-2033)
제6장 일본의 면역조직화학 시장 : 제품별 내역
항체
장비
시약
키트
제7장 일본의 면역조직화학 시장 : 용도별 내역
진단
약제 검사
제8장 일본의 면역조직화학 시장 : 최종사용자별 내역
병원 및 진단 연구소
연구기관
기타
제9장 일본의 면역조직화학 시장 : 경쟁 구도
개요
시장 구조
시장 기업 포지셔닝
주요 성공 전략
경쟁 대시보드
기업 평가 상한
제10장 주요 기업의 개요
제11장 일본의 면역조직화학 시장 : 업계 분석
촉진요인·억제요인·기회
Porter's Five Forces 분석
밸류체인 분석
제12장 부록
KSA
영문 목차
영문목차
Japan immunohistochemistry market size reached USD 177.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 321.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.1% during 2025-2033. The increasing prevalence of age-related diseases, presence of a strong healthcare infrastructure, growing awareness about personalized medicine, escalating funding and support by the government for medical research, and recent advancements in the field of pathology represent some of the key factors driving the market.
Immunohistochemistry (IHC) refers to a diagnostic and research technique that utilizes the principle of antigen-antibody interactions to identify specific proteins, antigens, or cells within tissue samples. It involves applying antibodies to a slide holding tissue sections, which then react with the antigen of interest and are visualized using chromogenic or fluorescent dyes. Immunohistochemistry is available in several types, including chromogenic, fluorescent, and multiplex. It is comprised of several components, such as primary antibodies, secondary antibodies, detection systems, and substrates. IHC offers multiple features, including high specificity, sensitivity, and the ability to localize cellular components accurately. It is widely used in oncology, neurobiology, infectious diseases, and tissue morphogenesis. Immunohistochemistry also finds application in forensics, environmental studies, and drug testing. It offers cost-effectiveness, speed, and the capability to handle large sample volumes. In addition to this, immunohistochemistry is known for its minimal invasiveness, ability to provide in situ analysis, quantitative capabilities, and seamless integration with automation technology for high-throughput screenings.
Japan Immunohistochemistry Market Trends:
The growing demand for immunohistochemistry, owing to the increasing prevalence of age-related diseases like Alzheimer's and cancer in Japan, is propelling the market growth. Additionally, the presence of a strong healthcare infrastructure, which supports the adoption of complex diagnostic technologies like IHC, is driving the market growth. Furthermore, the growing awareness about personalized medicine, which is enhancing the demand for targeted diagnostic techniques, is contributing to the market growth. In addition, the escalating funding and support by the government for medical research are catalyzing the market growth. Apart from this, the rising incidences of lifestyle diseases, necessitating early and precise diagnosis, are positively influencing the market growth. Moreover, recent advancements in the field of pathology that are making IHC more crucial, especially for tissue-based diagnoses, are fueling the market growth. Along with this, the rising cooperation between academia and industry, facilitating research and development (R&D) in IHC, is driving the market growth. In line with this, the increasing automation in IHC processes in Japan, which reduces manual errors and enhances throughput, is accelerating the market growth. Furthermore, the broadening application of IHC in drug development and testing, which is opening new avenues for expansion, is acting as another growth-inducing factor. Besides this, rapid improvements in imaging technologies that are enhancing the capabilities of IHC are stimulating the market growth. Additionally, the escalating healthcare expenditure in Japan, which allows for the integration of advanced diagnostic technologies, is providing a boost to the market growth across the country.
Japan Immunohistochemistry Market Segmentation:
Product Insights:
Antibodies
Primary Antibodies
Secondary Antibodies
Equipment
Slide Staining Systems
Tissue Microarrays
Tissue Processing Systems
Slide Scanners
Others
Reagents
Histological Stains
Blocking sera and Reagents
Chromogenic Substrates
Fixation Reagents
Stabilizers
Organic Solvents
Proteolytic Enzymes
Diluents
Kits
Application Insights:
Diagnostics
Cancer
Infectious Diseases
Cardiovascular Diseases
Autoimmune Diseases
Diabetes Mellitus
Nephrological Diseases
Drug Testing
End User Insights:
Hospitals and Diagnostic Laboratories
Research Institutes
Others
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
How has the Japan immunohistochemistry market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan immunohistochemistry market?
What is the breakup of the Japan immunohistochemistry market on the basis of product?
What is the breakup of the Japan immunohistochemistry market on the basis of application?
What is the breakup of the Japan immunohistochemistry market on the basis of end user?
What are the various stages in the value chain of the Japan immunohistochemistry market?
What are the key driving factors and challenges in the Japan immunohistochemistry?
What is the structure of the Japan immunohistochemistry market and who are the key players?
What is the degree of competition in the Japan immunohistochemistry market?
Table of Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Japan Immunohistochemistry Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 Japan Immunohistochemistry Market Landscape
5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)
6 Japan Immunohistochemistry Market - Breakup by Product
6.1 Antibodies
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2019-2024)
6.1.3 Market Segmentation
6.1.3.1 Primary Antibodies
6.1.3.2 Secondary Antibodies
6.1.4 Market Forecast (2025-2033)
6.2 Equipment
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2019-2024)
6.2.3 Market Segmentation
6.2.3.1 Slide Staining Systems
6.2.3.2 Tissue Microarrays
6.2.3.3 Tissue Processing Systems
6.2.3.4 Slide Scanners
6.2.3.5 Others
6.2.4 Market Forecast (2025-2033)
6.3 Reagents
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2019-2024)
6.3.3 Market Segmentation
6.3.3.1 Histological Stains
6.3.3.2 Blocking sera and Reagents
6.3.3.3 Chromogenic Substrates
6.3.3.4 Fixation Reagents
6.3.3.5 Stabilizers
6.3.3.6 Organic Solvents
6.3.3.7 Proteolytic Enzymes
6.3.3.8 Diluents
6.3.4 Market Forecast (2025-2033)
6.4 Kits
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2019-2024)
6.4.3 Market Forecast (2025-2033)
7 Japan Immunohistochemistry Market - Breakup by Application
7.1 Diagnostics
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2019-2024)
7.1.3 Market Segmentation
7.1.3.1 Cancer
7.1.3.2 Infectious Diseases
7.1.3.3 Cardiovascular Diseases
7.1.3.4 Autoimmune Diseases
7.1.3.5 Diabetes Mellitus
7.1.3.6 Nephrological Diseases
7.1.4 Market Forecast (2025-2033)
7.2 Drug Testing
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2019-2024)
7.2.3 Market Forecast (2025-2033)
8 Japan Immunohistochemistry Market - Breakup by End User
8.1 Hospitals and Diagnostic Laboratories
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2019-2024)
8.1.3 Market Forecast (2025-2033)
8.2 Research Institutes
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2019-2024)
8.2.3 Market Forecast (2025-2033)
8.3 Others
8.3.1 Historical and Current Market Trends (2019-2024)
8.3.2 Market Forecast (2025-2033)
9 Japan Immunohistochemistry Market - Competitive Landscape
9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant
10 Profiles of Key Players
10.1 Company A
10.1.1 Business Overview
10.1.2 Product Portfolio
10.1.3 Business Strategies
10.1.4 SWOT Analysis
10.1.5 Major News and Events
10.2 Company B
10.2.1 Business Overview
10.2.2 Product Portfolio
10.2.3 Business Strategies
10.2.4 SWOT Analysis
10.2.5 Major News and Events
10.3 Company C
10.3.1 Business Overview
10.3.2 Product Portfolio
10.3.3 Business Strategies
10.3.4 SWOT Analysis
10.3.5 Major News and Events
10.4 Company D
10.4.1 Business Overview
10.4.2 Product Portfolio
10.4.3 Business Strategies
10.4.4 SWOT Analysis
10.4.5 Major News and Events
10.5 Company E
10.5.1 Business Overview
10.5.2 Product Portfolio
10.5.3 Business Strategies
10.5.4 SWOT Analysis
10.5.5 Major News and Events
11 Japan Immunohistochemistry Market - Industry Analysis